Medical Product Safety Alerts

Europe’s drugs regulators will take another look at GlaxoSmithKline Plc’s new breast cancer pill Tyverb after new data showed a… »   

New data point to greater deaths in patients receiving Medtronic Inc’s AneuRx stent graft system, which treats artery bulges in… »   

U.S. health regulators plan to review whether a popular type of laser eye surgery is improving patients’ lives, a senior… »   

Eli Lilly and Co on Friday denied a report in The New York Times that said a senior executive had… »   

Taking vitamin C or E supplements, either individually or in combination, does not appear to lower the risk of dementia… »   

Close to 10 percent of US military personnel sent to Afghanistan are not suitable candidates for the antimalarial drug mefloquine,… »   

Cancer patients from the Southeastern United States who are treated with the drug cetuximab, known commercially as Erbitux, are far… »   

A Schering-Plough Corp drug aimed at reversing the effects of anesthesia appears effective, but it may not always be a… »   

U.S. health officials said Wednesday they had requested more information from GlaxoSmithKline Plc and other makers of asthma drugs to… »   

A U.S. court dismissed on Tuesday a lawsuit against U.S. health regulators over their decision to allow the sale… »   

GlaxoSmithKline Plc is scrapping two malaria drugs that may cause anaemia, dealing a blow to the global fight against the… »   

Baxter International Inc said on Thursday it was voluntarily recalling all remaining lots of its heparin injection and flush products… »   

The U.S. Food and Drug Administration is examining the way it tells the public about safety concerns with foods, prescription… »   

A nationwide recall has been issued for all lots of 25-μg/hour fentanyl transdermal systems (Duragesic, PriCara, a division of Ortho-McNeil-Janssen… »   

India’s patent office will consider this week whether to override patents on cancer drugs made by Pfizer and Roche… »